Sign up to save your podcasts
Or
Share ASCO Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Update – Key Changes
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ASCO Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Update – Key Changes
A rapid update of the 2026 Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer guideline, highlighting key updates across recommendations on predictive biomarker testing, first-line therapy, and second- or third-line therapyImmunotherapy and Targeted Therapy for Advanced Gastroesophageal CancerAmerican Society of Clinical OncologyFebruary 26th, 2026Guideline Summary: https://www.guidelinecentral.com/guideline/2352151/Full-Text: https://ascopubs.org/doi/full/10.1200/JCO-25-02958
View all episodes
By Guideline CentralA rapid update of the 2026 Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer guideline, highlighting key updates across recommendations on predictive biomarker testing, first-line therapy, and second- or third-line therapyImmunotherapy and Targeted Therapy for Advanced Gastroesophageal CancerAmerican Society of Clinical OncologyFebruary 26th, 2026Guideline Summary: https://www.guidelinecentral.com/guideline/2352151/Full-Text: https://ascopubs.org/doi/full/10.1200/JCO-25-02958